Table 2.

Multivariate model assessing the independent impact of T-tube use on the risk of EAD (EAD-O, MEAF) after groups matching

	EAD-O			MEAF
	OR	95% confidence interval	P	Regression coefficient	95% confidence interval	p
Donor age	1.024	1.002–1.046	0.031	.013	−.001 to .027	0.082
CIT	1.004	1.001–1.006	0.011	.015	.012 to .016	<0.001
WIT	1.143	1.019–1.167	<0.001	.024	.009 to .040	0.002
Child C	.911	.380–2.185	0.836	−.092	−.710 to .526	0.769
MELD	1.031	.977–1.087	0.265	.037	−.002 to .076	0.060
T-tube	1.097	1.003–4.836	0.002	.072	.026 to 0.187	0.002

Bold values indicate statistical significance

CIT cold ischemia time, EAD-O early allograft dysfunction according to Olthoff et al.’s definition, MELD model for end-stage liver disease, MEAF Model for Early Allograft Function, WIT warm ischemia time